Journal of Cancer Therapeutics and Research

ISSN 2049-7962

Downloads:

PDF /

ePUB

| Cited-by

| Post Comment | View Comments

| Order Reprints

| View Metrics

Original Research

PCI-24781 (abexinostat), a novel histone deacetylase inhibitor, induces reactive oxygen species-dependent apoptosis and is synergistic with bortezomib in neuroblastoma

Giselle Saulnier Sholler^1*, Erika A. Currier², Akshita Dutta¹, Marni A. Slavik³, Sharon A. Illenye⁴, Maria Cecilia F. Mendonca⁵, Julie Dragon³, Stephen S. Roberts⁶ and Jeffrey P. Bond³

*Correspondence: Giselle Saulnier Sholler Giselle.SaulnierSholler@helendevoschildrens.org

1. Department of Pediatrics, Helen DeVos Children's Hospital, Michigan State University, College of Human Medicine Grand Rapids, MI, USA.

Journal of Cancer Therapeutics and Research 2013 2:21doi: 10.7243/2049-7962-2-21

No comments have yet been made on this article.

Post Comment

Volume 2

Full text

PDF

Journal of Cancer Therapeutics and Research

PCI-24781 (abexinostat), a novel histone deacetylase inhibitor, induces reactive oxygen species-dependent apoptosis and is synergistic with bortezomib in neuroblastoma

Standards & Guidelines

Indexing sources

Services

Social promotions

Citation tools

More Links